Valuation: Rapid Micro Biosystems, Inc.

Market Cap 105M 91.51M 85.17M 78.2M 148M 10.05B 150M 1B 394M 5B 395M 387M 16.77B P/E 2026 *
-2.29x
P/E 2027 * -2.7x
Enterprise Value 105M 91.51M 85.17M 78.2M 148M 10.05B 150M 1B 394M 5B 395M 387M 16.77B EV / Sales 2026 *
2.68x
EV / Sales 2027 * 2.26x
Free-Float
86.1%
Yield 2026 *
-
Yield 2027 * -
1 day+0.95%
1 week+7.04%
1 month+23.84%
3 months-15.81%
6 months-49.16%
Current year-26.55%
1 week 1.95
Extreme 1.95
2.15
1 month 1.7
Extreme 1.7
2.26
Current year 1.66
Extreme 1.66
4.94
1 year 1.66
Extreme 1.66
4.94
3 years 0.58
Extreme 0.58
4.94
5 years 0.58
Extreme 0.58
25.93
10 years 0.58
Extreme 0.58
27.04
Manager TitleAgeSince
Chief Executive Officer 57 2014-09-30
Director of Finance/CFO 56 2018-09-30
Chief Tech/Sci/R&D Officer - 2025-04-30
Director TitleAgeSince
Director/Board Member 56 2018-09-30
Director/Board Member 57 2014-09-30
Director/Board Member 77 2016-03-14
Date Insider Type Main position Quantity % Market Cap.
7/24/26 Fiscal year

Director

7,016 0.0155%
7/22/26 Fiscal year

Chief Executive Officer

2,804 0.0062%
3/11/26 Sell

Chief Financial Officer

7,480 0.0188%
Change 5-day change 1-year change 3-year change Capi.($)
+0.95%+7.04%-35.65%+108.82% 105M
-0.43%+1.06%+24.03%+3.71% 212B
-0.61%+1.82%-1.07%-24.39% 137B
+0.10%+4.69%-26.86%+12.57% 125B
+1.59%+5.60%-55.67%-7.68% 69.46B
-0.98%+4.16%+8.50%+7.08% 49.56B
+6.02%+7.82%-17.08%-20.95% 47.2B
-0.25%-0.14%+21.91%+8.35% 39.08B
-0.79%+0.70%+29.97%+29.32% 37.05B
+0.00%+5.67%+116.67%+8.20% 30.97B
Average +0.64%+3.57%+6.47%+12.50% 74.77B
Weighted average by Cap. +0.41%+2.80%+3.91%-0.64%

Financials

2026 *2027 *
Net sales 39.3M 34.16M 31.8M 29.2M 55.13M 3.75B 55.99M 375M 147M 1.87B 148M 144M 6.26B 46.58M 40.49M 37.69M 34.6M 65.34M 4.45B 66.35M 444M 174M 2.21B 175M 171M 7.42B
Net income -44.7M -38.86M -36.17M -33.21M -62.71M -4.27B -63.68M -426M -167M -2.12B -168M -164M -7.12B -39.07M -33.96M -31.61M -29.02M -54.81M -3.73B -55.65M -373M -146M -1.86B -147M -143M -6.23B
Net Debt - -
Logo Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Employees
171
Date Price Change Volume
26-07-31 US$2.130 +0.95% 20,558
26-07-30 US$2.110 +2.93% 127,603
26-07-29 US$2.050 -0.49% 47,344
26-07-28 US$2.060 +2.49% 98,705
26-07-27 US$2.010 +1.01% 77,533
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.130USD
Average target price
6.667USD
Spread / Average Target
+212.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RPID Stock